Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-008355

10% owner bought 1,965 shares at $13.38 ($26,292)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2021-04-19 Purchase +1,965 $13.38 $26,292 4,811,509 D
Open-market purchases · 1,965 sh · avg $13.38 · $26,292
Loading xslF345X03/doc1.xml…